Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,583 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT00260585Recruiting
Esophageal risk and tissue registry study
This study collects information and, if you already need blood tests or procedures, may take extra small tissue samples (biopsies) to better understand esophageal-related conditions. It may help researchers learn about risk and future management for people with certain esophagus or reflux-related diagnoses.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT01805869Recruiting
Teeth removal study using leftover tissue for research
This study looks at people who need wisdom tooth (third molar) removal and collects the leftover tissue after extraction. The goal is to use these samples to help dental research, while making sure the procedure can be done safely.
Bethesda, MarylandAges 16–50 - NCT00574327Recruiting
Barrett’s and reflux registry at the Kansas City VA
This study follows people with confirmed Barrett’s esophagus (with or without concerning cell changes) and people who have reflux symptoms, to better understand how these conditions progress. It may help by building a Barrett’s registry so doctors can learn which factors predict worsening over time.
Kansas City, MissouriAges 18 years+ - NCT00004847RecruitingPhase 1
Understanding and Diagnosing Pheochromocytoma and Paraganglioma
This study helps doctors better understand and diagnose pheochromocytoma and paraganglioma—rare tumors that release stress hormones and cause high blood pressure and other symptoms. Researchers will study your medical history, blood and urine tests, imaging scans, and genetic information to improve how these conditions are found and understood.
Bethesda, MarylandAges 3–120 - NCT02000895Recruiting
Studying birth factors in preterm and term mother-infant pairs
This study looks at how biological factors at birth differ between preterm and term babies, and how they relate to the mother and baby together. It may help doctors better understand early-life influences for newborn care.
Miami, FloridaAges Up to 10 years - NCT01633489Recruiting
LAL deficiency patient registry
This study keeps a protected record of people with Lysosomal Acid Lipase (LAL) deficiency to learn more about the condition over time. It may help researchers better understand how patients are doing and support future studies.
Phoenix, ArizonaAges Any age - NCT00032513Recruiting
Genetic study of chronic active Epstein-Barr virus disease
This research study looks for genetic factors that may explain why some people develop severe, long-lasting Epstein-Barr virus (EBV) infection. Researchers will study blood and tissue samples from patients with this rare condition, their healthy relatives, and unrelated volunteers to understand the disease better.
Bethesda, MarylandAges 1–120 - NCT00272883Recruiting
Study genes in congenital muscle weakness
This research study looks at genes and molecules to better understand congenital myopathies (birth-related muscle weakness). It may help explain the cause of symptoms and improve future diagnoses for you and your family.
Boston, MassachusettsAges Any age - NCT00009243Recruiting
Understanding How Strokes Develop: A Research Study
This study follows people who have had or are at risk for stroke to understand what causes strokes and how they develop over time. By participating, you help researchers learn more about stroke prevention and treatment.
Washington D.C., District of ColumbiaAges 18–120 - NCT00470327Recruiting
Study of how interstitial lung disease naturally changes
This study looks at how interstitial lung disease (lung scarring) typically progresses over time. It may help researchers understand what to expect and what changes to watch for.
Chicago, IllinoisAges 18 years+ - NCT01403402Recruiting
Study of congenital muscle disease patients and their families
This trial collects health information from patients with certain inherited (genetic) muscle diseases and from their families. It may help researchers better understand the disease and improve care by learning what symptoms and treatments patients experience over time.
Lakewood, CaliforniaAges Any age - NCT01200953Recruiting
Study care after contact with serious infectious germs
This study helps doctors manage people who may have been exposed to, infected with, or are recovering from dangerous infectious germs (including emerging outbreaks). It may help by setting safe evaluation and care steps after these high-risk exposures.
Bethesda, MarylandAges 3–99 - NCT02026843Recruiting
Testing eye fluid markers in chorioretinal eye diseases
This study looks at substances (“biomarkers”) in the clear fluid inside the eye to better understand several eye conditions that affect vision. Your results may help doctors learn how these diseases work and how treatments might be chosen.
Daegu, KyungsangpookdoAges 20–80 - NCT00091871Recruiting
Understanding familial high eosinophil disease in families
This study follows families with a genetic condition that causes high levels of white blood cells called eosinophils. Researchers want to understand how the disease develops and changes over time to help predict who may get worse and how to treat it better.
Bethesda, MarylandAges 1–100 - NCT01496625Recruiting
Biobank study for retinal diseases and comparison samples
This study collects and stores blood and eye-related medical information to help researchers better understand retinal diseases, including age-related macular degeneration and diabetic retinopathy. Your samples may also be used to compare people with retinal disease to people without it.
Bethesda, MarylandAges 2–120 - NCT00398177Recruiting
Study blood and tissue changes in lymphoma and Hodgkin’s
This study looks at samples of tissue removed during routine procedures to better understand Hodgkin’s disease and non-Hodgkin’s lymphoma. It may help researchers learn more about what these cancers look like in tissue.
Stanford, CaliforniaAges 18 years+ - NCT00196742Recruiting
Fabry disease registry and pregnancy follow-up
This study collects health information from people with Fabry disease and specifically from pregnant people with Fabry disease. It helps researchers better understand the condition and how pregnancy affects health, using information you already experience in routine care.
Birmingham, AlabamaAges Any age - NCT00327860Recruiting
Kidney disease in children study that follows patients over time
This is a long-term study that watches children and young adults with chronic kidney disease to understand how the illness changes and to improve care. You may be asked to complete regular visits and questionnaires, and your kidney function will be tracked over time.
Kansas City, MissouriAges 6 months–22 years - NCT00567073Recruiting
Register pregnant people with Pompe disease for pregnancy data
This study keeps a special record of pregnancies in people with Pompe disease to learn more about pregnancy outcomes and newborn information. It does not test a drug by itself—it collects health information to improve future care.
Phoenix, ArizonaAges Any age - NCT01752738Recruiting
Study of gut microbial metabolites in chronic kidney disease
This trial studies how substances made by gut microbes travel in people with chronic kidney disease. You may be asked to have a planned colonoscopy so researchers can measure intestinal samples and better understand kidney disease.
Leuven, Vlaams BrabantAges 18–85 - NCT00692939RecruitingPhase 1/Phase 2
Stem cell transplant for people with Crohn’s who need new options
This trial studies whether an “autologous” stem cell transplant (using your own cells) can improve Crohn’s disease that has not responded to standard treatments. It may help people who have ongoing, hard-to-control Crohn’s even after medicines and/or who have complications that make surgery risky.
Pittsburgh, PennsylvaniaAges 10–60 - NCT00842283Recruiting
Study of how new blood vessels affect skin diseases
This study looks at how new blood vessel growth may be involved in skin conditions. It may help researchers learn whether blocking this process could become a future treatment, and you may contribute by having a skin biopsy.
Irvine, CaliforniaAges 16 years+ - NCT01245179RecruitingPhase 1
Panobinostat for adults with severe sickle cell
This early-phase study tests panobinostat, a medicine aimed at reducing sickle-cell problems, in adults with severe disease. It’s mainly looking at safety and whether it can improve blood-related issues that drive pain and complications.
Augusta, GeorgiaAges 18 years+ - NCT01900132Recruiting
Measures nerve and muscle signals in healthy people and patients
This study uses a painless electrical method to record how muscles and nerves work over time. It aims to better understand normal patterns (healthy volunteers) and to learn how these signals change in people with neuromuscular or movement-related conditions.
Bethesda, MarylandAges 2–110
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,583 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.